Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 31

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 31
---
 to continue to grow our revenue and overall business, our business, operating results, and financial
condition would be harmed.

If we are unable to generate significant revenue or secure additional financing, we may be unable to implement our business plan and grow our business.

We have incurred operating losses in 2022 but operating
income in 2023. We believe the proceeds from our private offering, together with our existing cash, will enable us to fund our operations
for at least 12 months from the date of this prospectus. We have based this estimate on assumptions that may prove to be wrong, and
we could use our available capital resources sooner than we expect.

There is uncertainty regarding our ability to grow
our business without additional financing. We have no agreements, commitments, or understandings to secure additional financing at this
time. Our long-term future growth and success are dependent upon our ability to continue selling our services, generate cash from operating
activities and obtain additional financing. We may be unable to continue selling our products and services, generate sufficient cash from
operations, sell additional shares of Common Stock or borrow additional funds. Our inability to obtain additional cash could have a material
adverse effect on our ability to grow our business to a greater extent than we can with our existing financial resources.

We may require additional capital to support our business and objectives, and this capital might not be available on acceptable terms, if at all.

We intend to continue to make investments to support
our business and will require additional funds to respond to business challenges, including the need to develop new features or enhance
our existing services, expand into additional markets or acquire complementary businesses and technologies. Accordingly, we may in the
future engage in equity and debt financings to secure additional funds. If we raise additional funds through future issuances of equity
or convertible debt securities, our stockholders, including investors in this offering, could suffer significant dilution, and any new
equity securities we issue could have rights, preferences, and privileges superior to those of holders of our Common Stock. Any debt financing
we secure in the future could also contain restrictive covenants relating to our capital-raising activities and other financial and operational
matters, which may make it more difficult for us to obtain additional capital and pursue business opportunities, including potential acquisitions.
We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or
financing on terms satisfactory to us when we require it, our ability